Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Pozycja w akcjach #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Cena akcji
$12.33
Ostatnia synchronizacja: 2026-08-31
Kapitalizacja rynkowa
$428.31M
Zmiana (1 dzień)
0.49%
Zmiana (1 rok)
39.01%
Kraj
US
Handel Fennec Pharmaceuticals Inc. (FENC)

Kategoria

Historia stopy dywidendy dla Fennec Pharmaceuticals Inc. (FENC)
Stopa dywidendy (TTM) dla Fennec Pharmaceuticals Inc. (symbol akcji: FENC) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Fennec Pharmaceuticals Inc. (FENC) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji